Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Respiratory Medicine Case Reports|July 7, 2018
Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS)Paul Zarogoulidis, Stella Laskou, Athanasios Katsaounis, et al.
International Journal of General Medicine|March 16, 2012
Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infectionsPaul Zarogoulidis, Dimitrios Glaros, Theodoros Kontakiotis, et al.
Oncology Letters|December 2, 2015
Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patientsEirini Papadopoulou, Nikolaos Tsoulos, Angeliki Tsirigoti, et al.
Anticancer Research|April 25, 2023
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'Giannis Mountzios, Anna Koumarianou, Helena Linardou, et al.
Expert Review of Medical Devices|January 23, 2021
Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and consPaul Zarogoulidis, Haidong Huang, Jun Zhou, et al.
Cell Reports. Medicine|April 27, 2022
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failureEvangelos J Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Pageof 7